machineMD

🎉 We’re thrilled to announce that machineMD has been awarded the prestigious Innosuisse Certificate! This milestone signifies our readiness for sustainable growth and underscores the innovation driving our mission to revolutionize brain diagnostics. 🚀 A heartfelt thanks to Innosuisse and our coaches Armin W. Mäder and Dr. Heiko Visarius for guiding us through this transformative journey. The challenges were worth it, and the excitement has only just begun! Here’s to shaping the future of neuro-ophthalmology and making cutting-edge diagnostics accessible to all. 🌍💡 Let’s take the next bold steps together! 🧠👁️ #NeuroOphthalmology #Telemedicine #Ophthalmology #Neurology #StartupsSwitzerland #SwissMedTech #Innovation #DigitalHealth #HealthTech #Innosuisse #MedicalDevices #FutureOfHealthcare

Virtual Reality Pupillography swings the flashlight on Glaucoma Management     Relative Afferent Pupillary Defect (RAPD) measurements reliably detected asymmetries in optic nerve damage in glaucoma patients and, moreover, a combination of standard automated perimetry and RAPD led to improved prediction of the peripapillary retinal nerve fiber layer thickness, as measured by OCT. In the future, this may enable the use of pupillary light reflex over time to monitor glaucomatous optic nerve damage in a single eye.    A pilot study by Karim El-Koussy, René Höhn, Mariana Falcão, Ph.D., Bruno Hauser, Avantika Naidu PT PhD, and Mathias Abegg, combined neos™ pupillometry tests with standard automated perimetry and OCT to evaluate whether RAPD could sufficiently distinguish between the two eyes in asymmetric glaucoma and thus lay the foundation for using the pupillary light reflex (PLR) of a single eye to monitor progression longitudinally.     Read the Study in Thieme – klinische Monatsblätter für Augenheilkunde:     https://lnkd.in/e-fjE3Fj    #Telemedicine #Opthalmology #Neurology #SitemMedTechHub #NeuroOphthalmology #startupswitzerland #swissmedtech #TranslationalMedicine #glaucoma #Optometry

A new medical device changes the workflow of a practice - and opens up new possibilities. For the ebovis ophthalmology practice in Zurich, neos™ was the missing piece of the puzzle that made it possible to offer a complete, standardized, instrument-based eye examination. Today, neos™ is an integral part of this examination, which is carried out by an optician. The data is uploaded to a secure data cloud and analyzed remotely by two ophthalmologists. An example that could set a new standard - check out our movie. Many thanks to ebovis for the cooperation and valuable insights!    #startupswitzerland #Opththalmology #Neurology #NeuroOphthalmology #Optometry     https://lnkd.in/eD_ExfTZ 

Yesterday, we hosted Marie Reynders (MD, PhD candidate) at the IIT for a spontaneous talk co-hosted by our colleague Giovanni Bertolini (project lead) at the Institute of Optometry, in connection to an industry-academia collaboration project with machineMD as a partner. Marie shared with us how she discovered virtual reality as a diagnostics tool, specifically for persistent postural-perceptual dizziness. It was great to have you with us & learn from you Marie! cc Samuel Schenk, Luca Fluri, Oscar Alanso, Arzu Çöltekin

Zurich is home to ebovis, the world's first ophthalmology practice to offer a standardized, complete, apparative eye examination. The neos™ examination device developed by machineMD plays an important role in this. For the first time, it enables a comprehensive, automated neuro-ophthalmological examination.The people behind ebovis are neuro-ophthalmologist Dr. Mathias Abegg, ophthalmologist Dr. Sven Hirsch-Hoffmann and general practitioner Dr. Markus Abegg. With ebovis, they show that a efficient, high-quality, examination of eye structure and function can be performed by a medical assistant or optician alone - making eye care accessible for all. Read more about it in our article: https://lnkd.in/ePrYVwmy and watch our video: https://lnkd.in/eD_ExfTZ Many thanks to ebovis and Tanja Veljkovic, Markus Abegg, Sven Hirsch-Hoffmann, Mathias Abegg for these valuable insights into their clinical practice. #startupswitzerland #Opththalmology #Neurology #NeuroOphthalmology #Optometry 

The International Society for Clinical Eye Tracking (ISCET) has developed a #survey to help understand how #eyetrackers are currently used in #clinicalpractice and explore the development of future #clinicalguidelines. ISCET is inviting responses to the survey here: 🌐 https://lnkd.in/eeeV29EE 𝘐𝘚𝘊𝘌𝘛 𝘢𝘯𝘥 𝘵𝘩𝘪𝘴 𝘴𝘶𝘳𝘷𝘦𝘺 𝘢𝘳𝘦 𝘦𝘯𝘵𝘪𝘳𝘦𝘭𝘺 𝘪𝘯𝘥𝘦𝘱𝘦𝘯𝘥𝘦𝘯𝘵 𝘰𝘧 𝘮𝘢𝘤𝘩𝘪𝘯𝘦𝘔𝘋. 𝘐𝘧 𝘺𝘰𝘶 𝘳𝘦𝘲𝘶𝘪𝘳𝘦 𝘢𝘯𝘺 𝘧𝘶𝘳𝘵𝘩𝘦𝘳 𝘪𝘯𝘧𝘰𝘳𝘮𝘢𝘵𝘪𝘰𝘯, 𝘱𝘭𝘦𝘢𝘴𝘦 𝘤𝘰𝘯𝘵𝘢𝘤𝘵 𝘋𝘳 Gemma Arblaster 𝘧𝘳𝘰𝘮 The University of Sheffield 𝘢𝘯𝘥 𝘵𝘩𝘦 𝘐𝘚𝘊𝘌𝘛 𝘴𝘶𝘳𝘷𝘦𝘺 𝘸𝘰𝘳𝘬𝘪𝘯𝘨 𝘨𝘳𝘰𝘶𝘱.

🏆 machineMD wins the 𝐕𝐈𝐕𝐄 𝐗𝐑 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐂𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞 🏆 The VIVE XR Healthcare Challenge is a special prize of the Healthcare Innovation World Cup® powered by HTC VIVE. The Top 3 finalists included ORamaVR and VRAIn, who brought their innovative solutions to the spotlight on the opening day of MEDICA - Leading International Trade Fair. 🌐 Read the Press Release: https://lnkd.in/e3CurCNs Congratulations also to the winners of the 16th Healthcare Innovation World Cup, who shared the podium with machineMD:  Samphire Neuroscience, MedicubeX Ltd and pheal. These finalists were evaluated by an excellent panel of expert jurors: Oriana Di Marco STMicroelectronics, Nina Wöss Female Founders, June Hsieh HTC VIVE, Eva-Maria Leitinger Siemens Healthineers, Evangeline Loh Emergo by UL, Jan Engels HTGF | High-Tech Gründerfonds, Michael Byczkowski SAP, Josef Hayoz CSEM, Borut Kastelic EBV Elektronik, and Thomas Waldmann Würth Elektronik Group. A big thank you to the hosts Dr. Sonja Sulzmaier, Christian Stammel and André Lönne

Today with neos as a Class IIa Device at the 28. Strabologische Kinder & NeuroOpthalmologische Falldemos. Thanks to Kantonsspital St.Gallen KSSG and Team Augenklinik Prof. Dr. Valmaggia & Dr. Hildebrand. #NeuroOphthalmologie, #VR, #DACH 🇩🇪 🇦🇹 🇨🇭

Thanks to everyone who made the first neos™ Symposium at Sitem StartUp Club (SSC) a success:  - Axel Petzold - for his very interesting presentation about Internuclear Ophthalmoplegia #INO #MS  - Mathias Abegg - who gave us an insight into his clinical experience with neos™  - speakers from the machineMD team: Dominic Senn, Ana Coito, PhD, Pia Massatsch, Nadine de Bernardi, Dominik Brügger and Samuel Schenk, who gave us valuable insights into the further development of neos™.  - Angela Hulliger from Souvvy, who treated us to culinary delights with her team.     A big thank you goes to the audience: neos™ pioneers from all over Switzerland, interested doctors, optometrists, opticians, researchers, and our friends at VON HOFF AG. The dialogue with all of them is very important to us. Together we can continue innovating at machineMD to further our vision for a world where people receive a fast, accurate, and early diagnosis of neurological disorders.    #startupswitzerland #Opththalmology #Neurology #NeuroOphthalmology #Optometry

One year of research work with machineMD technology in Bochum: For the past year, PD Dr Anke Salmen and her team from the Department of Neurology at St. Josef-Hospital, Bochum University Hospital have been using the innovative technology from machineMD in their research to better understand neurological diseases and identify new biomarkers with a focus on inflammatory diseases of the central nervous system - including Multiple Sclerosis.  In the spotlight are visual disturbances and new methods to assess these diseases. More than 400 patients and control subjects have already been examined. The first results are very promising. Discover more insights in Dr. Anke Salmen's interview: https://lnkd.in/eU7SMDaM